Europe Liver Disease Diagnostics Market

Europe Liver Disease Diagnostics Market By End User (Hospitals, Laboratories and Other End Users), By Diagnosis Technique (Imaging, Biopsy, Endoscopy, Laboratory tests and Other Diagnosis Techniques), By Country, Industry Analysis and Forecast, 2020 - 2026

Report Id: KBV-4392 Publication Date: July-2020 Number of Pages: 83
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Liver Disease Diagnostics Market, by End User
1.4.2 Europe Liver Disease Diagnostics Market, by Diagnosis Technique
1.4.3 Europe Liver Disease Diagnostics Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Europe Liver Disease Diagnostics Market by End User
3.1 Europe Hospitals Market by Country
3.2 Europe Laboratories Market by Country
3.3 Europe Other End Users Market by Country

Chapter 4. Europe Liver Disease Diagnostics Market by Diagnosis Technique
4.1 Europe Imaging Market by Country
4.2 Europe Biopsy Market by Country
4.3 Europe Endoscopy Market by Country
4.4 Europe Laboratory tests Market by Country
4.5 Europe Other Diagnosis Techniques Market by Country

Chapter 5. Europe Liver Disease Diagnostics Market by Country
5.1 Germany Liver Disease Diagnostics Market
5.1.1 Germany Liver Disease Diagnostics Market by End User
5.1.2 Germany Liver Disease Diagnostics Market by Diagnosis Technique
5.2 UK Liver Disease Diagnostics Market
5.2.1 UK Liver Disease Diagnostics Market by End User
5.2.2 UK Liver Disease Diagnostics Market by Diagnosis Technique
5.3 France Liver Disease Diagnostics Market
5.3.1 France Liver Disease Diagnostics Market by End User
5.3.2 France Liver Disease Diagnostics Market by Diagnosis Technique
5.4 Russia Liver Disease Diagnostics Market
5.4.1 Russia Liver Disease Diagnostics Market by End User
5.4.2 Russia Liver Disease Diagnostics Market by Diagnosis Technique
5.5 Spain Liver Disease Diagnostics Market
5.5.1 Spain Liver Disease Diagnostics Market by End User
5.5.2 Spain Liver Disease Diagnostics Market by Diagnosis Technique
5.6 Italy Liver Disease Diagnostics Market
5.6.1 Italy Liver Disease Diagnostics Market by End User
5.6.2 Italy Liver Disease Diagnostics Market by Diagnosis Technique
5.7 Rest of Europe Liver Disease Diagnostics Market
5.7.1 Rest of Europe Liver Disease Diagnostics Market by End User
5.7.2 Rest of Europe Liver Disease Diagnostics Market by Diagnosis Technique

Chapter 6. Company Profiles
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.1.5.2 Acquisition and Mergers:
6.1.5.3 Approvals:
6.2 F. Hoffmann-La Roche Ltd.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Approvals:
6.3 Boston Scientific Corporation
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Acquisition and Mergers:
6.4 Siemens AG (Siemens Healthineers)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.4.5.2 Acquisition and Mergers:
6.4.5.3 Product Launches and Product Expansions:
6.5 Bayer AG
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 Merck & Co., Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expenses
6.7 Sanofi S.A.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.8 Novartis AG
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.9 Pfizer, Inc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expense
6.1 Randox Laboratories Limited
6.10.1 Company Overview
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo